Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             53 results found
no title author magazine year volume issue page(s) type
1 ABEP as primary chemotherapy for Hodgkin's disease Zulian, Gilbert B.
1992
28 10 p. 1727-1729
3 p.
article
2 Additional ecological evidence: Lipids and breast cancer mortality among women aged 55 and over in China Marshall, James R.
1992
28 10 p. 1720-1727
8 p.
article
3 A new look at tumour immunology Bodmer, Walter
1992
28 10 p. 1761-1762
2 p.
article
4 Anti-neoplastic action of peritoneal macrophages following oral administration of ether analogues of lysophospholipids Ngwenya, Benjamin Z.
1992
28 10 p. 1637-1642
6 p.
article
5 Antitumour effect and symptomatic control with interferon α 2b in patients with endocrine active tumours Schöber, Ch
1992
28 10 p. 1664-1666
3 p.
article
6 Breast awareness: What do we really mean? Faulder, Carolyn
1992
28 10 p. 1595-1596
2 p.
article
7 Cancer incidence in the province of Limburg, The Netherlands Schouten, Leo J.
1992
28 10 p. 1752-1755
4 p.
article
8 Cancer incidence registration and trends in the department of Doubs, France Schraub, S.
1992
28 10 p. 1759-1760
2 p.
article
9 Cancer in Oman Jaffer, M.A.
1992
28 10 p. 1772-
1 p.
article
10 Cardiomyopathy after acute myocardial infarction after therapy with interleukin-2 and tumour infiltrating lymphocytes Ravaud, Alain
1992
28 10 p. 1772-
1 p.
article
11 Care and costs for advanced cervical cancer Ballegooijen, Marjolein van
1992
28 10 p. 1703-1708
6 p.
article
12 CD10 expression in B-chronic lymphocytic leukaemia Molica, Stefano
1992
28 10 p. 1771-
1 p.
article
13 Cell proliferation kinetics of human gastric carcinoma: An immunohistochemical study with a monoclonal antibody against DNA polymerase-α Saitoh, Kiyoshi
1992
28 10 p. 1642-1646
5 p.
article
14 Changes of lymphocyte subsets after local irradiation for early stage breast cancer and seminoma testis: long-term increase of activated (HLA-DR+) T cells and decrease of “naive” (CD4-CD45R) T lymphocytes De Ruysscher, Dirk
1992
28 10 p. 1729-1734
6 p.
article
15 Clinical oncology: Case presentations from oncology centres—2. Carcinoid of the larynx Govaerts, Paul J.
1992
28 10 p. 1755-1758
4 p.
article
16 Clinical oncology: Case presentations from oncology centres. Intensive treatment of poor prognosis gastrointestinal lymphoma Pettengell, R.
1992
28 10 p. 1742-1747
6 p.
article
17 c-myc gene amplification in selected node-negative breast cancer patients correlates with high rate of early relapse Roux-Dosseto, M
1992
28 10 p. 1600-1604
5 p.
article
18 Differences in the level of DNA double-strand breaks in human tumour cell lines following low dose-rate irradiation Cassoni, Anna M.
1992
28 10 p. 1610-1614
5 p.
article
19 Dilemmas in the development of cytoxic drug analogues Marsoni, S.
1992
28 10 p. 1594-1595
2 p.
article
20 Downmodulation of c-myc expression by interferon γ and tumour necrosis factor α precedes growth arrest in human melanoma cells Osanto, Susanne
1992
28 10 p. 1622-1627
6 p.
article
21 DT-diaphorase activity correlates with sensitivity to the indoloquinone EO9 in mouse and human colon carcinomas Walton, Michael I.
1992
28 10 p. 1597-1600
4 p.
article
22 Early assessment of a new anticancer drug analogue — are the historical comparisons obsolete? The French experience with pirarubicin Herait, P.
1992
28 10 p. 1670-1676
7 p.
article
23 Effects of recombinant human erythropoietin on clonogenic growth of primary human tumour specimens in vitro Bauer, Enno
1992
28 10 p. 1769-
1 p.
article
24 Epidemiology and biology of multiple myelona Millar, Barbara C
1992
28 10 p. 1763-
1 p.
article
25 Epirubicin in previously untreated patients with small cell lung cancer: A phase II study by the EORTC lung cancer cooperative group Quoix, Elisabeth A.
1992
28 10 p. 1667-1670
4 p.
article
26 Flavone acetic acid induced changes in human endothelial permeability: Potentiation by tumour-conditioned medium Watts, Margaret E.
1992
28 10 p. 1628-1632
5 p.
article
27 Heterogeneity of tumour necrosis factor production in renal cell carcinoma Waase, Inge
1992
28 10 p. 1660-1664
5 p.
article
28 High-dose rapid schedule chemotherapy for disseminated neuroblastoma Pearson, Andrew D.J.
1992
28 10 p. 1654-1659
6 p.
article
29 Immunorecognition of ganglioside epitopes: Correlation between affinity and cytotoxicity of ganglioside antibodies Dippold, Wolfgang
1992
28 10 p. 1605-1610
6 p.
article
30 Immunostaining of cathepsin D in breast cancer: Quantification by computerised image analysis and correlation with cytosolic assay Maudelonde, T.
1992
28 10 p. 1686-1691
6 p.
article
31 Malignant melanoma treated with natural interferons alfa and beta and DAV Nagatani, Tetsuo
1992
28 10 p. 1774-
1 p.
article
32 Mediastinal non-seminomatous germ cell tumours: Effectiveness of platinum, etoposide, bleomycin combination chemotherapy plus adjunctive surgery Berruti, Alfredo
1992
28 10 p. 1773-
1 p.
article
33 Multiple myeloma in two sisters Abreu, Isabel
1992
28 10 p. 1774-1775
2 p.
article
34 Neuron-specific enolase as a prognostic factor in metastatic malignant melanoma Wibe, Einar
1992
28 10 p. 1692-1695
4 p.
article
35 News Namer, M.
1992
28 10 p. 1764-1767
4 p.
article
36 No correlation between ras, c-myc and c-jun proto-oncogene expression and prognosis in advanced carcinoma of cervix Symonds, R.P
1992
28 10 p. 1615-1617
3 p.
article
37 Octreotide and interferon alfa: A new combination for the treatment of malignant carcinoid tumours Janson, Eva M.Tiensuu
1992
28 10 p. 1647-1650
4 p.
article
38 Oral contraceptives and breast cancer—Institute of Medicine, 1991 Ellman, R.
1992
28 10 p. 1763-1764
2 p.
article
39 Pharmacological purging of syngeneic bone marrow ex vivo: Effect of treatment with doxorubicin and lonidamine on normal and leukaemic cells of DBA 2 mice Sandrelli, Antonella
1992
28 10 p. 1633-1636
4 p.
article
40 Phase II study of interferon alfa-2a and dacarbazine in advanced melanoma 1992
28 10 p. 1719-1720
2 p.
article
41 Photodynamic therapy Dougherty, Thomas J.
1992
28 10 p. 1734-1742
9 p.
article
42 Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinoma Åvall-Lundqvist, Elisabeth H.
1992
28 10 p. 1695-1702
8 p.
article
43 Prognostic value of progesterone receptor after long-term follow-up in primary breast cancer Pichon, M.F.
1992
28 10 p. 1676-1680
5 p.
article
44 Progress, problems and priorities in quality of life research Hopwood, Penelope
1992
28 10 p. 1748-1752
5 p.
article
45 Recent changes in the surgical management of T1 2 breast cancer in England Morris, Jenny
1992
28 10 p. 1709-1712
4 p.
article
46 Recombinant interleukin 2 for metastatic renal cell carcinoma in haemodialysis patients Buter, J.
1992
28 10 p. 1770-1771
2 p.
article
47 Screening of new anticancer agents in vitro using panels of human cell lines derived from non-seminomatous germ cell tumours and transitional cell carcinomas of the bladder Masters, John R.W.
1992
28 10 p. 1617-1622
6 p.
article
48 The assessment of sexual function in cancer patients Cull, Ann M.
1992
28 10 p. 1680-1686
7 p.
article
49 The influence of intramuscular 4-hydroxyandrostenedione on peripheral aromatisation in breast cancer patients Jones, A.L.
1992
28 10 p. 1712-1716
5 p.
article
50 Thyroid function 10–18 years after mantle field irradiation for Hodgkin's disease Peerboom, Pauline F.
1992
28 10 p. 1716-1718
3 p.
article
51 Toremifene for recurrent and advanced endometrial carcinoma Mäenpää, Juhani U.
1992
28 10 p. 1768-
1 p.
article
52 Treatment of metastatic carcinoid tumour with recombinant interferon alfa Joensuu, Heikki
1992
28 10 p. 1650-1653
4 p.
article
53 Vascular damage and tumour response Murray, J.C.
1992
28 10 p. 1593-1594
2 p.
article
                             53 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands